AngioSafe announced the company’s emergence from stealth with the FDA 510(k) clearance of its flagship product, the Santre ...
Coronary bifurcation lesions pose a significant challenge in interventional cardiology, accounting for approximately 15–25% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback